Opinion of the Advisory Committee on mergers given at its meeting of 18 March 2015 regarding a draft decision relating to Case M.7265 — Zimmer/Biomet — Rapporteur: Poland

26.2.2016 EN Official Journal of the European Union C 74/11 Opinion of the Advisory Committee on mergers given at its meeting of 18 March 2015 regarding a draft decision relating to Case M.7265 — Zimmer/Biomet Rapporteur: Poland (2016/C 74/06) Concentration 1. The Advisory Committee agrees with the Commission that the notified operation constitutes a concentration within the meaning of Article 3(1)(b) of the Merger Regulation. 2. The Advisory Committee agrees with the Commission that the notified merger has a Union dimension pursuant to Article 1(2) of the Merger Regulation. Market definition 3. The Advisory Committee agrees with the Commission’s definitions of the relevant product and geographic markets in the draft decision. Horizontal Effects 4. The Advisory Committee agrees with the Commission's assessment that the proposed operation is likely to give rise to non-coordinated horizontal effects that would significantly impede effective competition through the creation or strengthening of a dominant position in the following markets: (a) the markets for partial knee implants in Austria, Belgium (including Luxembourg), Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Slovenia, Spain, Sweden and United Kingdom; (b) the markets for elbows implants in Austria, Belgium (including Luxembourg), Czech Republic, Denmark, France, Germany, Italy, Norway, Portugal, Spain, Sweden and United Kingdom; and (c) the...